Showing results (3081-3090 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|July 24, 2009
Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignanciesGadi Gazit Bornstein, Christophe Quéva, Mohammad Tabrizi, et al.
Investigational New Drugs|August 28, 2009
Scaling the time-course of myelosuppression from rats to patients with a semi-physiological modelLena E Friberg, Marie Sandström, Mats O Karlsson
Investigational New Drugs|September 5, 2009
Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylateKuniaki Shirao, Toshirou Nishida, Toshihiko Doi, et al.
Investigational New Drugs|March 31, 2010
Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cellsHong Zhu, Jun Zhang, Na Xue, et al.
Investigational New Drugs|March 31, 2010
A novel activity from an old compound: Manzamine A reduces the metastatic potential of AsPC-1 pancreatic cancer cells and sensitizes them to TRAIL-induced apoptosisEsther A Guzmán, Jacob D Johnson, Patricia A Linley, et al.
Investigational New Drugs|April 7, 2010
Oral enzastaurin in prostate cancer: a two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic diseaseRobert Dreicer, Jorge Garcia, Maha Hussain, et al.
Investigational New Drugs|September 25, 2009
Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport systemAnna Kruczynski, Isabelle Vandenberghe, Arnaud Pillon, et al.
Investigational New Drugs|April 24, 2009
Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agentMi Kyung Kwak, Keun Hur, Ji Eun Yu, et al.
Investigational New Drugs|December 4, 2008
Boldine: a potential new antiproliferative drug against glioma cell linesDaniéli Gerhardt, Ana Paula Horn, Mariana Maier Gaelzer, et al.
Investigational New Drugs|March 28, 2009
Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxisJing Wu, Baogang Zhang, Min Wu, et al.
Pageof 372